Opsoclonus-myoclonus syndrome in a patient with an anaplastic oligoastrocytoma

J Neurooncol. 2015 Jun;123(2):315-6. doi: 10.1007/s11060-015-1783-4. Epub 2015 Apr 12.

Authors

Carl A Gold¹, Andrew B Lassman, Yazmín Odia

Affiliation

¹ Department of Neurology (C.A.G, A.B.L., Y.O.) and Herbert Irving Comprehensive Cancer Center (A.B.L., Y.O.), New York-Presbyterian Hospital/Columbia University Medical Center, New York, NY, USA.

PMID: 25864100
DOI: 10.1007/s11060-015-1783-4

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Astrocytoma / complications*
Brain Neoplasms / complications*
Female
Humans
Immunosuppressive Agents / therapeutic use
Opsoclonus-Myoclonus Syndrome / drug therapy
Opsoclonus-Myoclonus Syndrome / etiology*
Opsoclonus-Myoclonus Syndrome / pathology
Prognosis

Substances

Immunosuppressive Agents